CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,491,115
- in 20 filings, $14.5M under 10b5-1 plans
Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-11 | ROBINS HARLAN S Chief Scientific Officer | Option exercise | +3,895 | $6.32 | $25K | 73,255 |
| 2021-06-11 | ROBINS HARLAN S Chief Scientific Officer | Sale | −3,895 | $38.41 | $150K | 69,360 |
| 2021-06-11 | ROBINS HARLAN S Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −3,895 | 116,850 | ||
| 2021-06-10 | ROBINS HARLAN S Chief Scientific Officer | Option exercise | +3,895 | $6.32 | $25K | 73,255 |
| 2021-06-10 | ROBINS HARLAN S Chief Scientific Officer | Sale | −1,100 | $36.77 | $40K | 72,155 |
| 2021-06-10 | ROBINS HARLAN S Chief Scientific Officer | Sale | −2,795 | $37.87 | $106K | 69,360 |
| 2021-06-10 | ROBINS HARLAN S Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −3,895 | 120,745 | ||
| 2021-06-09 | ROBINS HARLAN S Chief Scientific Officer | Option exercise | +3,895 | $6.32 | $25K | 73,255 |
| 2021-06-09 | ROBINS HARLAN S Chief Scientific Officer | Sale | −3,395 | $35.91 | $122K | 69,860 |
| 2021-06-09 | ROBINS HARLAN S Chief Scientific Officer | Sale | −500 | $36.50 | $18K | 69,360 |
| 2021-06-09 | ROBINS HARLAN S Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −3,895 | 124,640 | ||
| 2021-06-09 | Cohen Chad M Chief Financial Officer | Option exercise | +10,000 | $6.55 | $66K | 31,604 |
| 2021-06-09 | Cohen Chad M Chief Financial Officer | Sale | −10,000 | $35.60 | $356K | 21,604 |
| 2021-06-09 | Cohen Chad M Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −10,000 | 110,000 | ||
| 2021-06-08 | Cohen Chad M Chief Financial Officer | Option exercise | +10,000 | $6.55 | $66K | 31,604 |
| 2021-06-08 | Cohen Chad M Chief Financial Officer | Sale | −8,401 | $36.90 | $310K | 23,203 |
| 2021-06-08 | Cohen Chad M Chief Financial Officer | Sale | −1,599 | $37.85 | $61K | 21,604 |
| 2021-06-08 | Cohen Chad M Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −10,000 | 120,000 | ||
| 2021-05-18 | GRIFFIN MICHELLE RENEE Director | Option exercise | +2,500 | $7.80 | $20K | 4,004 |
| 2021-05-18 | GRIFFIN MICHELLE RENEE Director | Sale | −2,500 | $35.00 | $88K | 1,504 |
Page 46 of 120 · 2,386 trades